Division of General Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA.
Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, USA.
J Gen Intern Med. 2019 Nov;34(11):2630-2633. doi: 10.1007/s11606-019-05223-z. Epub 2019 Aug 5.
Primary care physicians are increasingly incorporating screening tools for substance use disorders (SUDs) and referral to treatment into their practice. Despite efforts to provide access to treatment, patients with SUDs remain at an increased risk of mortality, both from overdose and from general medical conditions. Advance care planning (ACP) is recommended for patients with chronic, progressive medical conditions such as malignancies or heart failure. Though SUDs are widely acknowledged to be chronic diseases associated with an increased risk of mortality, there has been little discussion on ACP in this population. ACP is a discussion regarding future care, often including selection of a surrogate decision-maker and completion of an advanced directive. ACP has been associated with better quality of end-of-life and care more consistent with patient preferences. Studies in other vulnerable populations have shown that marginalized and high-risk individuals may be less likely to receive ACP. Similarly, patients with SUDs may employ different decision-makers than that defined by law (i.e., friend vs. family member), increasing the importance of discussing patient values and social structure. Physicians should routinely conduct ACP conversations with patients with SUDs, especially those with chronic, progressive medical conditions and/or severe, uncontrolled substance use disorders.
初级保健医生越来越多地将物质使用障碍(SUD)筛查工具和治疗转介纳入其常规实践中。尽管努力提供治疗机会,但 SUD 患者的死亡率仍然居高不下,这既与药物过量有关,也与一般医疗状况有关。对于患有恶性肿瘤或心力衰竭等慢性、进行性疾病的患者,建议进行预先护理计划(ACP)。尽管 SUD 被广泛认为是与死亡率增加相关的慢性疾病,但针对该人群的 ACP 讨论却很少。ACP 是关于未来护理的讨论,通常包括选择代理人和完成高级指令。ACP 与更好的临终质量和更符合患者偏好的护理相关。在其他弱势群体中的研究表明,边缘化和高风险个体可能不太可能接受 ACP。同样,SUD 患者可能会使用不同于法律规定的决策者(即朋友与家庭成员),这增加了讨论患者价值观和社会结构的重要性。医生应定期与 SUD 患者进行 ACP 对话,特别是那些患有慢性、进行性医疗状况和/或严重、不受控制的物质使用障碍的患者。